Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study

•sFlt-1/PlGF at 24–28 weeks in high-risk women predicts most early PE/FGR cases.•Optimal diagnostic accuracy was obtained for sFlt-1/PlGF values >95th centile.•High-risk women with sFlt-1/PlGF ≤95th centile at 24–28 weeks can be reassured. To analyze the usefulness of a clinical protocol for earl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pregnancy hypertension 2018-07, Vol.13, p.279-285
Hauptverfasser: Herraiz, I., Simón, E., Gómez-Arriaga, P.I., Quezada, M.S., García-Burguillo, A., López-Jiménez, E.A., Galindo, A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•sFlt-1/PlGF at 24–28 weeks in high-risk women predicts most early PE/FGR cases.•Optimal diagnostic accuracy was obtained for sFlt-1/PlGF values >95th centile.•High-risk women with sFlt-1/PlGF ≤95th centile at 24–28 weeks can be reassured. To analyze the usefulness of a clinical protocol for early detection of preeclampsia and/or fetal growth restriction (PE/FGR) using, in previously selected pregnancies, the measurement of the sFlt-1/PlGF ratio at 24–28 weeks of gestation. Prospective observational cohort study carried out in a single tertiary hospital in Spain. 5601 consecutive singleton pregnancies with complete follow-up were included. High-risk women for PE/FGR were selected by combining data from maternal history and second trimester uterine artery Doppler. Subsequently these patients underwent intensive monitoring, including the measurement of the sFlt-1/PlGF ratio at 24–28 weeks to predict PE/FGR. Early, intermediate and late PE/FGR (delivery
ISSN:2210-7789
2210-7797
DOI:10.1016/j.preghy.2018.06.017